Back

GOLD AF registry - Discussion

17 March 2019 (14:40 - 14:45)
Organised by:
Congress Presentation Part of: Late-breaking trials 1 Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2019

10 More presentations in this session

Presentation thumbnail
A randomized clinical trial of cryoballoon vs. irrigated radiofrequency catheter ablation for atrial fibrillation:The CIRCA-DOSE Study
Doctor J. Andrade (Vancouver, CA)
Slides Video
Presentation thumbnail
CIRCA-DOSE Study - Discussion
Professor D. Scherr (Graz, AT)
Slides Video
Presentation thumbnail
Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation - AVATAR AF
Professor P. Kanagaratnam (London, GB)
Slides Video
Presentation thumbnail
Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation - Discussion
Professor J. Merino (Madrid, ES)
Slides Video
Presentation thumbnail
Quality of life and 12-month efficacy outcomes in paroxysmal and persistent af following pvi using the pvac gold ablation catheter: results from the multicenter GOLD AF registry
Professor L. Boersma (Nieuwegein, NL)
Slides Video

Access the full session

Session thumbnail
Late-breaking trials 1

The Event

Event poster

EHRA 2019

17 March 2019 14:40 CET
You may be interested in
thumbnail
Webinar
Registries to support implementation of care and trial design in heart failure
15 February 2022
thumbnail
Congress Presentation
Safety, efficiency and efficacy of catheter ablation in paroxysmal atrial fibrillation: insights from the Abbott United Registry for Ablation (AURA) registry
12 April 2026
thumbnail
Congress Session
ACNAP General Assembly
24 June 2023
thumbnail
Congress Session
Evolution of coronary artery disease diagnosis ... from stenosis to inflammation
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources